NOI - LC MS Analysis Processed Mouse Serum Samples

This is a non-competitive combined synopsis and solicitation issued under FAR Subpart 12.6 to acquire LC-MS analysis of 280 processed mouse serum samples using Seer, Inc.’s proprietary Proteograph Platform and Proteograph Analysis Suite (PAS). Conducted under FAR 12.603 and authorized by 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii), the acquisition is structured as a firm fixed price purchase order with no expectation of full and open competition, as Seer, Inc. is the exclusive provider of the required workflow, sample kits, and software. The solicitation, numbered 75N98026Q00465, was issued by the National Institutes of Health, Office of the Director, Office of Logistics and Acquisition Operations, and responds to a requirement for high-depth, quantitative proteomic profiling to support aging research biomarker discovery using the Thermo Scientific Orbitrap Astral Zoom MS instrument in data-independent acquisition mode. Proposals must be submitted electronically by June 8, 2026, at 9:00 AM EDT to nicholas.capobianco@nih.gov and must include all required representations, certifications, Unique Entity Identifier, Taxpayer Identification Number, business size certification, and a completed FAR 52.212-3 form. Offerors must demonstrate technical capability and include detailed pricing with unit and list prices, shipping and handling costs, F.O.B. point, delivery terms, and prompt payment discount terms. The contract, with a twelve-month base period from June 8, 2026, to June 7, 2027, requires delivery of electronic quantitative protein measurements, quality control metrics including assay success rates and coefficients of variation, a technical methods report, and progress updates submitted as PDF or MS Word files via email. All deliverables, including reports, recommendations, and data, are subject to unlimited rights owned by the National Institute on Aging as defined under FAR 27.401 and incorporated by reference via FAR 52.227-14. Invoicing must be processed through the Invoicing Processing Platform (IPP) with a three-way match and must align precisely with the purchase order line item. Seer, Inc. has been designated as the sole source based on their exclusive control of the Proteograph workflow, and the procurement falls below the simplified acquisition threshold